Want to join the conversation?
In 1Q17, $EL expects sales to grow 2-3% in constant currency. Restructuring and other charges are expected to be $80-100MM in FY17 with about $35-45MM in 1Q17. The company expects growth in many developed and emerging markets, particularly in Europe. Some macro issues are expected to impact the results, the company said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?